12:00 AM
Feb 17, 2014
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Innovimmune preclinical data

In a mouse model of chronic progressive experimental autoimmune encephalomyelitis (EAE), prophylactic treatment with oral INV-17 for 28 days prevented disease development and significantly reduced cumulative EAE scores vs....

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >